American College of Clinical Pharmacy
      Search      Cart
         

IDSAP 2025


Member Price:
$88.00
Nonmember Price:
$132.00
ASHP members, please call (913)492-3311 to receive member pricing. Your ASHP membership number and expiration date are required.
Release Date: May 15, 2025
BCIDP Deadline: May 15, 2026
ACPE Deadline: May 15, 2028

Editor(s): Dodds-Ashley L, Gross A
Publication Year: 2025
Format: PDF and ePub
Number of Pages: 200

Contents

Acinobacter

Pseudomonas aeruginosa

Enterics

Hepatitis C and Hepatitis B Viruses

Community Pharmacy Point-of-Care Test and Treat Programs for Respiratory Tract Infections

Herpesviruses in Immunocompromised Patients

Application of NHSN Antimicrobial Use and Resistance Data

Case Series: TJC/CMS Regulatory Updates

Beta-Lactam Therapeutic Drug Monitoring

Acinobacter

Faculty

Ashlan Kunz

Reviewers

Amanda L. Binkley, Pharm.D., BCIDP

Clinical Pharmacy Specialist Infectious Diseases Penn Presbyterian Medical center

Rupal K. Jaffa, Pharm.D., BCIDP, BCPS

Clinical Staff Pharmacist

Sarah B. Green, Pharm.D., BCIDP, AAHIVP

Clinical Pharmacy Specialist - Infectious Diseases Emory University Hospital

Pseudomonas aeruginosa

Faculty

Dana R. Bowers, Pharm.D., BCIDP, BCPS

Clinical Specialist-Infectious Diseases Kingman Regional Medical Center

Reviewers

Catherine Vu, BCIDP
Kelli A. Kronsberg, Pharm.D., BCIDP, BCPS
Lynn Chan, BCIDP

Enterics

Faculty

Brandon K. Hawkins, Pharm.D., BCIDP, AAHIVP

Assistant Professor University of Tennessee Health Science Center, College of Pharmacy

Reviewers

Heather L. Cox, Pharm.D., BCIDP

Lead Pharmacist, Infectious Diseases University of Virginia Health

Lindsay E. Donohue, Pharm.D., BCIDP

PGY2 Infectious Diseases Pharmacy Resident University of Virginia Health System

Hepatitis C and Hepatitis B Viruses

Faculty

Paulina Deming, Pharm.D.

Clinical Associate Professor: Pharmacy Practice & Administrative Sciences, College of Pharmacy, University of New Mexico, Albuquerque, New Mexico

Reviewers

HaYoung Ryu, Pharm.D.

Oregon Health & Science University

Jessica Cottreau, Pharm.D., BCIDP, BCPS

Associate Professor, RFUMS College of Pharmacy, North Chicago, Illinois

Esther O. Fasanmi, Pharm.D., BCIDP, BCPS, AAHIVP

Clinical Pharmacist - Ambulatory (HIV/Hepatitis C) JPS Health Network

Community Pharmacy Point-of-Care Test and Treat Programs for Respiratory Tract Infections

Faculty

Renee Koski, Pharm.D.

Professor, Pharmacy Practice Ferris State University College of Pharmacy

Michael E. Klepser, Pharm.D., FCCP

Professor of Pharmacy, Ferris State University, Kalamazoo, Michigan

Reviewers

Michael Postelnick, B.S.Pharm, BCPS

Senior Infectious Diseases Pharmacist, Northwestern Memorial Hospital, Lake In The Hills, Illinois

Ron W. Welch, Pharm.D., BCIDP, BCPS

Baptist Memorial Hospital

Herpesviruses in Immunocompromised Patients

Faculty

Nancy N. Vuong, BCIDP, BCPS, Clinical Pharmacy Specialist, M.D. Anderson Cancer Center

Reviewers

Caleb Rux, Pharm.D., BCIDP

Transplant Infectious Diseases Clinical Pharmacist Loyola University Medical Center

Jennifer Sparks, Pharm.D., BCIDP, BCPS

Assistant Clinical Professor Marshall University School of Pharmacy

Dipti Patel, Pharm.D., BCCCP, BCIDP, BCPS

Critical Care Clinical Pharmacist Southern Regional Health System

Application of NHSN Antimicrobial Use and Resistance Data

Faculty

Natasha Pettit, Pharm.D., BCIDP

Clinical Pharmacist, Infectious Diseases University of Chicago Medical Center

Reviewers

Julie Akers, Pharm.D., FWSPA

Executive Associate Dean Washington State University College of Pharmacy and Pharmaceutical Sciences

Hunter O. Rondeau, Pharm.D., BCIDP

Regional Antimicrobial Stewardship Coordinator SSM Health

Samira Zantout, Pharm.D., BCIDP, BCPS

Clinical Pharmacist Avera McKennan

Case Series: TJC/CMS Regulatory Updates

Faculty

Arsheena Yassin, Pharm.D., BCIDP

ID Clinical Pharmacist

Reviewers

Dominic Chan, Pharm.D., BCIDP, BCPS

Legacy Health

Kari A. McCracken, Pharm.D., MBA, BCIDP, BCPS

Clinical Pharmacy Manager St. John Medical Center

Jessica Leri, Pharm.D., BCIDP

Lead Clinical Pharmacist ChristianaCare

Beta-Lactam Therapeutic Drug Monitoring

Faculty

Veena Venugopalan, Pharm.D., FCCP, BCIDP

Clinical Associate Professor University of Florida

Barbara Santevecchi, Pharm.D., BCIDP

Clinical Assistant Professor of Infectious Disease University of Florida College of Pharmacy

Reviewers

Nathaniel J. Rhodes, Pharm.D., MSC, BCPS, AQ-ID

Associate Professor of Pharmacy Practice Midwestern University

YEHIA MAHMOUD EL KHAWLY, Pharm.D., BCIDP

CLINICAL PHARMACIST Hamad Medical Corporation -Al Wakra Hospital

CPE Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of BCIDP.

BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/

To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.

The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.

The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.

Target Audience: BCIDP

Contents

Acinobacter

Activity Number:
Contact Hour(s):
Activity Type: Application Based

Pseudomonas aeruginosa

Activity Number:
Contact Hour(s):
Activity Type: Application Based

Enterics

Activity Number:
Contact Hour(s):
Activity Type: Application Based

Hepatitis C and Hepatitis B Viruses

Activity Number:
Contact Hour(s):
Activity Type: Application Based

Community Pharmacy Point-of-Care Test and Treat Programs for Respiratory Tract Infections

Activity Number:
Contact Hour(s):
Activity Type: Application Based

Herpesviruses in Immunocompromised Patients

Activity Number:
Contact Hour(s):
Activity Type: Application Based

Learning Objectives

1. Evaluate epidemiologic and patient risk factors associated with herpesvirus infections

2. Develop prophylactic therapy plans against herpesviruses for the immunocompromised host (hematopoietic stem cell transplant and solid organ transplant)

3. Design therapeutic treatment plans for patients with herpes simplex viruses (HSV), varicella-zoster virus (VZV)/herpes zoster (HZ), and cytomegalovirus (CMV)

4. Develop a plan to detect and manage drug resistant herpesvirus infections

Application of NHSN Antimicrobial Use and Resistance Data

Activity Number:
Contact Hour(s):
Activity Type: Application Based

Case Series: TJC/CMS Regulatory Updates

Activity Number:
Contact Hour(s):
Activity Type: Application Based

Beta-Lactam Therapeutic Drug Monitoring

Activity Number:
Contact Hour(s):
Activity Type: Application Based

Commercial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.